The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Leukemia, Prolymphocytic

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Leukemia, Prolymphocytic


High impact information on Leukemia, Prolymphocytic


Chemical compound and disease context of Leukemia, Prolymphocytic


Biological context of Leukemia, Prolymphocytic


Anatomical context of Leukemia, Prolymphocytic


Gene context of Leukemia, Prolymphocytic


Analytical, diagnostic and therapeutic context of Leukemia, Prolymphocytic


  1. Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group. Döhner, H., Ho, A.D., Thaler, J., Stryckmans, P., Sonneveld, P., de Witte, T., Lechner, K., Lauria, F., Bödewadt-Radzun, S., Suciu, S. J. Natl. Cancer Inst. (1993) [Pubmed]
  2. Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia. Gauwerky, C.E., Huebner, K., Isobe, M., Nowell, P.C., Croce, C.M. Proc. Natl. Acad. Sci. U.S.A. (1989) [Pubmed]
  3. Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies. Faderl, S., Thomas, D.A., O'Brien, S., Garcia-Manero, G., Kantarjian, H.M., Giles, F.J., Koller, C., Ferrajoli, A., Verstovsek, S., Pro, B., Andreeff, M., Beran, M., Cortes, J., Wierda, W., Tran, N., Keating, M.J. Blood (2003) [Pubmed]
  4. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Herling, M., Khoury, J.D., Washington, L.T., Duvic, M., Keating, M.J., Jones, D. Blood (2004) [Pubmed]
  5. The expression of CD22 (Leu 14) and CD11c (LeuM5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis. Miller, M.L., Fishleder, A.J., Tubbs, R.R. Am. J. Clin. Pathol. (1991) [Pubmed]
  6. Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1. Künstle, G., Laine, J., Pierron, G., Kagami Si, S., Nakajima, H., Hoh, F., Roumestand, C., Stern, M.H., Noguchi, M. Mol. Cell. Biol. (2002) [Pubmed]
  7. No germline ATM mutation in a series of 16T-cell prolymphocytic leukemias. Stoppa-Lyonnet, D., Laugé, A., Sigaux, F., Stern, M.H. Blood (2000) [Pubmed]
  8. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Chan, J.K., Sin, V.C., Wong, K.F., Ng, C.S., Tsang, W.Y., Chan, C.H., Cheung, M.M., Lau, W.H. Blood (1997) [Pubmed]
  9. High frequency of somatic mutations in the VH genes expressed in prolymphocytic leukemia. Davi, F., Maloum, K., Michel, A., Pritsch, O., Magnac, C., Macintyre, E., Salomon-Nguyen, F., Binet, J.L., Dighiero, G., Merle-Béral, H. Blood (1996) [Pubmed]
  10. Complete remission in T-cell prolymphocytic leukemia with 2-chlorodeoxyadenosine. Palomera, L., Domingo, J.M., Agulló, J.A., Soledad Romero, M. J. Clin. Oncol. (1995) [Pubmed]
  11. Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia. Kantarjian, H.M., Childs, C., O'Brien, S., Huh, Y., Beran, M., Schachner, J., Koller, C., Keating, M.J. Am. J. Med. (1991) [Pubmed]
  12. D-verapamil and L-verapamil are equally effective in increasing vincristine accumulation in leukemic cells in vitro. Gruber, A., Peterson, C., Reizenstein, P. Int. J. Cancer (1988) [Pubmed]
  13. Expression of the mdr3 gene in prolymphocytic leukemia: association with cyclosporin-A-induced increase in drug accumulation. Nooter, K., Sonneveld, P., Janssen, A., Oostrum, R., Boersma, T., Herweijer, H., Valerio, D., Hagemeijer, A., Baas, F. Int. J. Cancer (1990) [Pubmed]
  14. Cytochemistry of acid hydrolases in chronic B- and T-cell leukemias. Crockard, A., Chalmers, D., Matutes, E., Catovsky, D. Am. J. Clin. Pathol. (1982) [Pubmed]
  15. TCL1 is activated by chromosomal rearrangement or by hypomethylation. Yuille, M.R., Condie, A., Stone, E.M., Wilsher, J., Bradshaw, P.S., Brooks, L., Catovsky, D. Genes Chromosomes Cancer (2001) [Pubmed]
  16. Solution structure of the recombinant human oncoprotein p13MTCP1. Yang, Y.S., Guignard, L., Padilla, A., Hoh, F., Strub, M.P., Stern, M.H., Lhoste, J.M., Roumestand, C. J. Biomol. NMR (1998) [Pubmed]
  17. Clonal evolution of T-cell prolymphocytic leukemia to a T-large-cell lymphoma. A morphologic and immunologic study. Forman, S.J., Nathwani, B.N., Woda, B.A., Paladugu, R.R., Farbstein, M.J. Arch. Pathol. Lab. Med. (1985) [Pubmed]
  18. Fludarabine-induced cytogenetic remission in prolymphocytic leukemia. Marlton, P., McCarthy, C., Taylor, K. Am. J. Hematol. (1992) [Pubmed]
  19. c-myc and c-fos expression during interferon-alpha therapy for hairy cell leukemia. Lehn, P., Sigaux, F., Grausz, D., Loiseau, P., Castaigne, S., Degos, L., Flandrin, G., Dautry, F. Blood (1986) [Pubmed]
  20. CD52 expression in T-cell large granular lymphocyte leukemia--implications for treatment with alemtuzumab. Osuji, N., Del Giudice, I., Matutes, E., Morilla, A., Owusu-Ankomah, K., Morilla, R., Dunlop, A., Catovksy, D. Leuk. Lymphoma (2005) [Pubmed]
  21. Phenotypic transformation of CD52(pos) to CD52(neg) leukemic T cells as a mechanism for resistance to CAMPATH-1H. Birhiray, R.E., Shaw, G., Guldan, S., Rudolf, D., Delmastro, D., Santabarbara, P., Brettman, L. Leukemia (2002) [Pubmed]
  22. 5' region and exon 7 mutations of the TP53 gene in two cases of B-cell prolymphocytic leukemia. De Angeli, C., Cuneo, A., Aguiari, G., Roberti, M.G., Piva, N., Moretti, S., Cavazzini, P., Castoldi, G., del Senno, L. Cancer Genet. Cytogenet. (1998) [Pubmed]
  23. Recurrent molecular deletion of the 12p13 region, centromeric to ETV6/TEL, in T-cell prolymphocytic leukemia. Hetet, G., Dastot, H., Baens, M., Brizard, A., Sigaux, F., Grandchamp, B., Stern, M.H. Hematol. J. (2000) [Pubmed]
  24. IL-2-induced growth of CD8+ T cell prolymphocytic leukemia cells mediated by NF-kappaB induction and IL-2 receptor alpha expression. Arima, N., Matsushita, K., Suruga, Y., Ohtsubo, H., Fujiwara, H., Hidaka, S., Arimura, K., Kukita, T., Yamaguchi, K., Fukumori, J., Tanaka, H. Leuk. Res. (1998) [Pubmed]
  25. The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle. Golay, J.T., Clark, E.A., Beverley, P.C. J. Immunol. (1985) [Pubmed]
  26. Molecular cloning of a t(11;14)(q13;q32) translocation breakpoint centromeric to the BCL1-MTC. Galiègue-Zouitina, S., Collyn-d'Hooghe, M., Denis, C., Mainardi, A., Hildebrand, M.P., Tilly, H., Bastard, C., Kerckaert, J.P. Genes Chromosomes Cancer (1994) [Pubmed]
  27. Interleukin-2 can induce proliferation of leukemic B-cells in prolymphocytic leukemia. Panayotides, P., Porwit, A., Lenkei, R., Reizenstein, P. Eur. J. Haematol. (1987) [Pubmed]
WikiGenes - Universities